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Abstract 
This paper explores the recent literature surrounding comorbid depression and COPD. The literature 
reveals a high prevalence of depression in patients with COPD and some evidence that the depression is 
a result of the disease. The literature highlights the negative impact of depression on quality of life and a 
possible impact on mortality. Depression also negatively impacts on compliance and smoking cessation. 
Treatment of depression in COPD, particularly by cognitive behavioral therapy, has positive impact on 
quality of life. Tricyclic antidepressants have a positive impact on mood and COPD, but side effects limit 
their use. The advent of the new antidepressants may improve acceptability and outcomes, but the 
research is yet to be undertaken. Physical rehabilitation may have a positive impact on mood. This paper 
highlights the difficulty in screening for depression in patients with COPD due to the overlap of symptoms 
between the two diseases. Despite the difficulties, it is important to recognize and treat depression in 
patients with COPD because of the significant likelihood of improvement in quality of life. 
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Abstract: This paper explores the recent literature surrounding comorbid depression and
COPD. The literature reveals a high prevalence of depression in patients with COPD and
some evidence that the depression is a result of the disease. The literature highlights the
negative impact of depression on quality of life and a possible impact on mortality. Depression
also negatively impacts on compliance and smoking cessation. Treatment of depression in
COPD, particularly by cognitive behavioral therapy, has positive impact on quality of life.
Tricyclic antidepressants have a positive impact on mood and COPD, but side effects limit
their use. The advent of the new antidepressants may improve acceptability and outcomes,
but the research is yet to be undertaken. Physical rehabilitation may have a positive impact on
mood. This paper highlights the difficulty in screening for depression in patients with COPD
due to the overlap of symptoms between the two diseases. Despite the difficulties, it is important
to recognize and treat depression in patients with COPD because of the significant likelihood
of improvement in quality of life.
Keywords: depressive disorder, chronic obstructive pulmonary disease, patient compliance,
smoking cessation
Introduction
Chronic obstructive pulmonary disease is a common chronic lung disease that has a
significant impact on the quality of life of those with the condition. It impacts on
patients’ lives through restriction of activities, interference with sleep, and limitation
of social life. It is not surprising that COPD significantly affects the sufferer’s mental
health. The association between COPD and anxiety and depression is well recognized.
This paper explores recent research highlighting the impact of COPD on mood and
vice versa. It is based on the author’s knowledge of the literature surrrounding the
interaction between depression and chronic disease, supplemented by a search of
MEDLINE for literature relating to depression or depressive disorder and “pulmonary
disease, chronic obstructive”.
Prevalence
There is a well documented association between COPD and anxiety or depression
(Dowson et al 2001; Mikkelsen et al 2004; Kunik et al 2005). In respiratory clinics,
the prevalence of depression is around 40% (de Godoy DV and de Godoy RF 2003;
Stage et al 2003; Yohannes et al 2003), while in the emergency department and general
practice it is lower (12%, Dahlen and Janson 2002; and 21.6%, van Manen et al
2002). In general practice, there seems to be a relationship between depression and
the severity of the COPD, with 25% of patients with severe COPD also having
depression, 19.6% of those with mild COPD, and 17.5% of those in the control group
(van Manen et al 2002). In all of the above studies, standard instruments (such as
Hamilton and Beck depression scores) were used to make the diagnosis of depression.
This is important, as the recognition and diagnosis of depression in nonpsychiatrist
practitioners is limited, especially at an isolated consultation (Bushnell 2004). The
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high prevalence of depression in patients attending a
respiratory clinic is not unexpected, as the majority of
patients will have more severe COPD than that seen
regularly in the general practice setting. This argument
assumes that the depression is caused by the COPD (see
below).
All of the above prevalence rates were determined by
diagnostic instruments. Whether screening for depression
should be undertaken in patients with COPD also depends
on the impact of the disease, its ease of treatment, and the
impact of the treatment. As demonstrated below, the
recognition and treatment of depression should lead to
significant improvements in quality of life.
Impact of depression on COPD
In patients with COPD seen in the emergency department,
the presence of anxiety or depression was associated with
significantly higher admission rates (52% of patients with
anxiety or depression compared with 19% of those without;
Dahlen and Janson 2002). This suggests that depression and
anxiety occur in patients with more severe COPD, or that
depression and anxiety lead to a worsening of the COPD.
In the same study, patients requiring readmission had higher
scores on the Hospital Anxiety and Depression (HAD) scale
than patients not requiring readmission.
In an outpatient population, the presence of depression
or anxiety led to a doubling of the number of days admitted
to hospital (Mikkelsen et al 2004). Depression was a better
predictor of reduction in activities of daily living than forced
expiratory volume in 1 second (FEV1) (Yohannes et al 2003).
In some studies, depression, among other factors, has been
associated with higher mortality (Almagro et al 2002), but
this has not been found in all studies (Yohannes et al 2002).
Depression in patients with COPD has a significant
detrimental impact on quality of life (QOL) (Clary et al
2002). A small study in the elderly demonstrated that the
reduction in FEV1 had the biggest impact on QOL, but mood
was also important (Peruzza et al 2003).
Depression also has other impacts on patients with
COPD. Sleep disturbance is common in COPD, and patients
with COPD and depression or arthritis are more likely to
have disturbed sleep (Bellia et al 2003). In patients on long-
term oxygen therapy, depression was associated with de-
creased preference for resuscitation (50% not for resuscitation
in depressed patients compared with 23% in non-depressed
patients; Stapleton et al 2005). The depression did not have
any effect on the preference for mechanical ventilation.
The impact of COPD on
depression
There have been limited studies of the impact of COPD on
depression. Pulmonary rehabilitation programs can result
in improvement of depression (Kozora et al 2002; Garuti et
al 2003; Goldberg et al 2004). Other studies have not
demonstrated this (de Godoy DV and de Godoy RF 2003).
Whether this is due to improved physical wellbeing,
involvement in group activities, or improvement in oxy-
genation is unknown.
In the literature on asthma, there is evidence that QOL
in patients with asthma and depression is worse than in those
patients suffering either alone (Goldney et al 2003). There
is also evidence in this literature that symptoms may reflect
depression severity rather than asthma severity (Rimington
et al 2001). Whether these findings also apply to COPD has
not been studied.
Treatment of depression in COPD
The treatment of depression in patients with COPD has been
the subject of a number of reviews (Clary et al 2002;
Mikkelsen et al 2004) that have demonstrated the
effectiveness of tricyclic antidepressant (TCA) medication
in improving mood but with little effect on the COPD.
Because of the side effects of TCA there has been a reticence
to use them (Clary et al 2002). The advent of selective
serotonin reuptake inhibitors (SSRIs) may change this, but
so far the studies have been very limited (Clary et al 2002).
Several reviews of cognitive behavioral therapy (CBT)
(Clary et al 2002; de Godoy DV and de Godoy RF 2003;
Mikkelsen et al 2004) have demonstrated its effectiveness
in improving physical as well as psychological wellbeing.
These reviews have supported the use of CBT as an adjunct
to pulmonary rehabilitation.
The positive impact of improving mood in response to
rehabilitation suggests that the diminished mood may be
secondary to COPD. A difficulty arises in that at least some
of the symptoms of depression, as measured in depression
rating instruments, may arise from the COPD itself.
Tiredness, lack of energy, weight loss, and disturbed sleep
are symptoms of both conditions.
The diminished cognition and mental slowing may be
attributable to hypoxia (Clary et al 2002; Mikkelsen et al
2004), and depression itself may be secondary to
corticosteroid administration (Mikkelsen et al 2004).
Treatment of COPD may improve the hypoxia and lead to a
reduction in corticosteroid administration. The association
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of mood with corticosteroid administration is complex, with
several possible outcomes. Clinical experience suggests that
a significant number of people taking corticosteroids have
an improvement in their mood, yet drug-induced psychosis
is also seen. People who are on reducing doses of cortico-
steroid medication may develop tiredness and joint pains.
The impact of corticosteroids in the individual patient is
idiosyncratic.
Cause and effect
There have been few longitudinal studies of the development
of depression in patients with COPD. The major study, the
Health and Retirement Study (Polsky et al 2005), followed
8387 adults aged 51–61 years for 10 years. Subjects were
reevaluated biennially. Part of this study examined the
occurrence of depressive symptoms after the diagnosis of
one of seven medical conditions. Chronic lung disease
(excluding asthma) was included in the analysis. Within two
years of diagnosis the hazard ratio for the development of
depressive symptoms was 2.21 (95% confidence interval
1.64–2.97). This compares with 3.55 for cancer and 1.45
for heart disease. Depressive symptoms developed 2–4 years
after the diagnosis of inflammatory arthritis. The Health and
Retirement Study supports the idea that depression in COPD
develops in response to the diagnosis of the disease.
COPD, depression, and smoking
A number of studies have demonstrated that patients with
COPD who also suffer from depression or anxiety are more
likely to be smokers (van Manen et al 2002; Wagena et al
2004). The primary association appears to be between
depression and smoking (Almeida and Pfaff 2005; Gulec et
al 2005). Anecdotally, psychiatrists report that cigarette
smoking appears to have an antidepressant effect. Generally,
depression severely limits the effectiveness of smoking
cessation programs (Cinciripini et al 2003; Freedland et al
2005).
Depression and compliance
On theoretical grounds, it has been assumed that depression
is associated with poor compliance. This has been confirmed
in studies that relate to asthma treatment. In a prospective
study, poor compliance (taking less than 70% of inhaled
medication) was associated with higher depression scores
at commencement of the study (Bosley et al 1995). Although
anxiety levels were also high, anxiety was not associated
with poor compliance. It is possible to postulate that anxiety
actually improves compliance, by focusing the patient on
their disease and its treatment. Other cross-sectional studies
have confirmed the findings of poor compliance being
associated with higher levels of depression (Cluley and
Cochrane 2001).
Screening for depression
Most of the studies described previously have used
diagnostic instruments to diagnose depression. A few have
used the “gold standard” of psychiatric interview. There have
not been any studies of screening instruments.
In the general literature on depression there have been
some attempts at developing screening tools, but these have
not always been successful. The most commonly examined
screening instruments are the one and two question screens
(Whooley et al 1997; Arroll et al 2003; Henkel et al 2004).
These studies demonstrate that the two questions, which
relate to the two essential criteria for the diagnosis of
depression, are effective. However, preliminary work
(Reddy et al 2005) indicates that such screening tests are
ineffective in patients with chronic diseases. Tiredness, low
energy, weight loss, and loss of interest occur in both
depression and COPD.
It would seem that instruments such as the Beck
Depression Inventory or the Hamilton Depression scale are
required. Unfortunately, these require some time for the
patient to complete and the practitioner to interpret. Using
them in busy clinical practice as screening instruments is
not practical. It would seem appropriate that screening tests
for depression in patients with COPD still need to be devised.
Conclusions
Depression is common in patients with COPD, and its
presence has a significant impact on the QOL of such patients
and may be associated with a higher mortality rate. It also
negatively affects compliance and smoking cessation.
Depression responds to treatment and the literature
suggests that cognitive behavioral therapy may be the
treatment of choice. Further research is required to determine
the impact of SSRIs in the treatment of depression in patients
with COPD and the cost benefit of screening for depression
in patients in different settings. Care needs to be taken in
developing screening tests for depression in patients
with COPD.
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